Table of Contents
<< Previous Issue | Aug 2006 (Vol: 2006, Issue: 74) | Next Issue >> |
- Section: Business Commentaries
-
The Culture of Deal Making
- Section: Cartoons
-
Due Diligence
- Section: Deal Trackers
-
Ceplene (histamine dihydrochloride)
- Section: Features
-
Medivir Refocuses its Pipeline via Tibotec Deals
-
Diagnosing Change: Celera Genomics' Strategic Drug Sell-Off
-
Deal Making Review: 2000-2005, with Projections for 2006
-
Therapy Focus: Atherosclerosis
- Section: General
-
Vertex Views Success on the Horizon
-
CrystaX Pharmaceuticals SL
- Section: Licensing
-
Mayne Pays US$34 M for Rights to SuperGen Oncology
-
Nastech and Amylin Sign Deal for Diabetes Nasal Spray
- Section: Mergers & Acquisitions
-
Barr and Actavis Battle for PLIVA
- Section: Research & Development
-
Mundipharma to Develop Sosei’s Fentanyl Pain Spray
-
J&J Active on the Deal Front